Open AccessP1739: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH IBERDOMIDE PLUS DEXAMETHASONE IN A PHASE 1B/2A OPEN‐LABEL DOSE ESCALATION STUDY
Author(s) -
Donk N. W.,
Guo S.,
Shi L.,
LordBessen J.,
Tang D.,
Karlin L.,
Weisel K.,
Ramasamy K.,
Abad P. C.,
Amin A.,
Amin S.,
Lonial S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849812.21433.44
Subject(s) - medicine , pomalidomide , lenalidomide , multiple myeloma , oncology , dexamethasone , cohort , population , interim analysis , clinical trial , environmental health